8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
2016 / Narrative review
This review evaluates current and emerging endoscopic bariatric therapies for obesity and associated cardio-metabolic comorbidities. Currently, two intragastric balloons have FDA approval for 6-month implantation in patients with a BMI of 30-40 kg/m². Additionally, full-thickness suturing has enabled primary endoscopic sleeve gastroplasty and Roux-en-Y gastric bypass revision as viable alternatives to surgery.
Goyal D, Watson RR Curr Gastroenterol Rep, 2016. PMID 27098813
2016 / Narrative review
This review examined the relationship between obesity and lower limb osteoarthritis (OA). A proven association exists between obesity and knee OA, with obese patients (BMI > 30 kg/m^2) more likely to require total knee arthroplasty (TKA). Evidence suggests obese patients face higher rates of short- to medium-term complications following TKA—such as wound infection, medical complications, and potentially early revision—but they can still benefit through improved function, quality of life, and satisfaction.
Shows an association, not proof of cause and effect.
Kulkarni K, Karssiens T, Kumar V, et al. Maturitas, 2016. PMID 27180156
2016 / Narrative review of intervention-based literature
This review evaluated intervention-based studies examining the effects of breakfast consumption, composition, and size on weight management markers and daily food intake. Overall, limited intervention evidence supports or refutes daily breakfast consumption for these outcomes, though evidence is accumulating for higher protein, fiber, and morning energy. However, most trials manipulating breakfast composition failed to control for habitual breakfast patterns or include a breakfast-skipping control group, leaving causal roles unclear.
Leidy HJ, Gwin JA, Roenfeldt CA, et al. Adv Nutr, 2016. PMID 27184285
2016 / Narrative review
This review summarizes the natural history and progression of non-alcoholic fatty liver disease (NAFLD). NAFLD ranges from bland steatosis to non-alcoholic steatohepatitis (NASH), with emerging data indicating that fibrosis is the most important histological predictor of liver- and non-liver-related death. Metabolic syndrome and its components play a key role in the histological progression of NAFLD, while hepatocellular carcinoma in non-cirrhotic liver is associated with metabolic syndrome and male gender. Beyond liver-related outcomes, cardiovascular disease and malignancy represent major causes of death in individuals with NAFLD.
Shows an association, not proof of cause and effect.
Calzadilla Bertot L, Adams LA Int J Mol Sci, 2016. PMID 27213358
2016 / Narrative review
This narrative review examined eight sets of dietary studies, comparing findings between randomised controlled trials (RCTs) and epidemiological studies (mostly cohort studies) covering blood pressure, body weight, cancer, and heart disease. While some study findings were consistent, others conflicted. The review noted that RCTs frequently enroll high-risk participants or those with disease history and follow them for only weeks or months, whereas cohort studies typically follow healthy subjects for 5 to 15 years. Consequently, RCT findings are not necessarily more reliable than well-designed prospective cohort studies.
Temple NJ Br J Nutr, 2016. PMID 27267302
2016 / Narrative review of randomized controlled trials
This review summarizes findings from the Bath Breakfast Project exploring morning fasting versus breakfast in lean and obese adults. Current evidence does not support a clear effect of consuming or skipping breakfast on body mass/composition, metabolic rate, or diet-induced thermogenesis. Daily energy intake was either unaffected or slightly lower when omitting breakfast due to compensatory feeding later in the day. However, both lean and obese adults expended less energy during the morning when remaining fasted compared to when consuming a prescribed breakfast, indicating compensatory adjustments in physical activity thermogenesis.
Betts JA, Chowdhury EA, Gonzalez JT, et al. Proc Nutr Soc, 2016. PMID 27292940
2016 / Narrative review
This narrative review evaluated observational and intervention studies on irregular meal patterns and cardiometabolic consequences. Few observational studies were found, but most suggested eating meals irregularly is associated with a higher risk of metabolic syndrome and cardiometabolic risk factors such as BMI and blood pressure. Additionally, two randomized controlled trials found that consuming meals regularly for 2 weeks versus an irregular pattern led to lower peak insulin and lower fasting total and LDL-cholesterol in lean and obese women. The authors noted the evidence is limited and highlighted the need for more large-scale studies with detailed dietary assessments.
Pot GK, Almoosawi S, Stephen AM Proc Nutr Soc, 2016. PMID 27327128
2016 / Narrative review of observational studies
This review examined data from cross-sectional surveys and longitudinal cohorts on global trends in time-of-day of energy intake and its relationship with obesity. A wide variation in time-of-day energy distribution was observed across countries and regions. Across eight cross-sectional surveys and two longitudinal cohorts identified for obesity outcomes, associations between time-of-day of energy intake and obesity varied widely, with several studies reporting a positive link between evening energy intake and obesity.
Shows an association, not proof of cause and effect.
Almoosawi S, Vingeliene S, Karagounis LG, et al. Proc Nutr Soc, 2016. PMID 27327252
2016 / Narrative review
This review discusses the relationship between chronodisruption (CD), circadian rhythms, and obesity. While mutations in clock genes are rare in humans (<1% of the population), single nucleotide polymorphisms in clock genes are common and relate to obesity and weight loss. The authors highlight that nutrigenetics and epigenetics show behaviors can interact with genetic risk variants, proposing that modifying what, how, and when we eat can serve as an effective tool to diminish CD and decrease obesity.
Lopez-Minguez J, Gómez-Abellán P, Garaulet M Proc Nutr Soc, 2016. PMID 27339810
2016 / Narrative review
This review summarizes the functional properties of spinach (Spinacia oleracea L.) and its bioactives across cell culture, animal, and human studies. Spinach contains phytochemicals and bioactives, such as glycolipids and thylakoids, that scavenge reactive oxygen species, modulate genes involved in metabolism and inflammation, and curb food intake by inducing satiety hormones. These biological activities contribute to anti-cancer, anti-obesity, hypoglycemic, and hypolipidemic properties, though spinach consumption remains relatively low compared to other leafy greens.
Roberts JL, Moreau R Food Funct, 2016. PMID 27353735
2016 / Narrative review
This mini-review develops the hypothesis that increased hydration promotes body weight loss, primarily through decreased feeding and fat loss via increased lipolysis. The hypothesis is built on animal studies linking renin-angiotensin system manipulations to increased drinking and reduced body weight, as well as an association between chronic hypohydration, elevated angiotensin II, and chronic diseases. Proposed mechanisms involve increased metabolism from hydration expanding cell volume. The author notes that human studies are consistent with this hypothesis for weight loss and reducing risk factors for obesity and type 2 diabetes.
Shows an association, not proof of cause and effect.
Thornton SN Front Nutr, 2016. PMID 27376070
2016 / Narrative review
This review discusses the role of diet and the gut microbiota in metabolic diseases such as obesity and type 2 diabetes. Findings from animal models and human studies indicate that the gut microbiota mediates dietary impacts on host metabolism. Current research is focusing on establishing causal relationships in humans and developing therapeutic interventions like personalized nutrition.
Sonnenburg JL, Bäckhed F Nature, 2016. PMID 27383980
2016 / Narrative review
Obesity affects 35% of US adults and increases the risk of many cancer types while being associated with poor outcomes. Clinical management of cancer patients currently remains largely identical between normal weight and obese individuals. This review summarizes literature exploring inflammation as a potential shared causal driver of cancer initiation and progression across different cancer types.
Kolb R, Sutterwala FS, Zhang W Curr Opin Pharmacol, 2016. PMID 27429211
2016 / Comprehensive narrative review
This review summarizes literature supporting the Canadian Diabetes Association's recommendation of plant-based diets (PBDs) for type 2 diabetes medical nutrition therapy. Large observational studies linked PBDs to a lower prevalence of type 2 diabetes. In intervention trials, PBDs were as effective or more effective than other diabetes diets for improving body weight, cardiovascular risk factors, insulin sensitivity, glycated hemoglobin, oxidative stress, and renovascular markers, while reducing the need for diabetes medications.
Rinaldi S, Campbell EE, Fournier J, et al. Can J Diabetes, 2016. PMID 27476051
2016 / Narrative review
This review provides an overview of the psychosocial burden associated with obesity and its comorbidities, which include cardiovascular disease, type 2 diabetes, sleep apnea, osteoarthritis, and cancer. It describes psychological changes commonly seen with weight loss, noting that evaluating psychosocial functioning is key to assessment and treatment planning. A particular focus is placed on psychosocial functioning in individuals with extreme obesity undergoing bariatric surgery.
Shows an association, not proof of cause and effect.
Sarwer DB, Polonsky HM Endocrinol Metab Clin North Am, 2016. PMID 27519139
2016 / Narrative review
This review evaluates the role of energy and nutrient timing in weight control. Observational studies on the topic are largely inconclusive due to methodological limitations. Experimental evidence does not support a causal role for eating frequency or breakfast skipping in weight control. However, emerging evidence suggests that eating irregularity and eating later in the day may be detrimental for weight control, though more studies are needed.
McCrory MA, Shaw AC, Lee JA Endocrinol Metab Clin North Am, 2016. PMID 27519140
2016 / Document analysis of clinical study reports, protocols, and publications
Researchers analyzed 8,716 pages of clinical study reports (CSRs) and protocols from seven randomized placebo-controlled trials of orlistat (4,225 participants) and compared them with published papers. Only 3% to 33% of investigator-reported adverse events appeared in publications due to post hoc filters, despite six of seven papers claiming all adverse events were recorded. In one trial, orlistat-treated participants experienced significantly more days with adverse events than placebo (22.7 d vs. 14.9 d, p < 0.0001) and more severe events, details omitted from CSRs and publications. A key limitation is that the analysis was restricted to one drug tested in the mid-1990s, which may not apply to newer drugs.
Schroll JB, Penninga EI, Gøtzsche PC PLoS Med, 2016. PMID 27529343
2016 / Narrative review
This review summarizes recent findings linking sleep and circadian rhythm disturbances to an increased risk of obesity. Sleep and circadian disruptions adversely affect food choices, hunger, appetite, and energy balance, and are associated with lifelong metabolic consequences when occurring in childhood or early adulthood. Upregulation of the endocannabinoid system, altered temporal distribution of caloric intake, and changes in the gut microbiome were identified as potential mechanisms linking sleep loss and circadian misalignment to obesity. Manipulations of the timing of food intake are suggested as potential preventive countermeasures.
Shows an association, not proof of cause and effect.
Broussard JL, Van Cauter E Curr Opin Endocrinol Diabetes Obes, 2016. PMID 27584008
2016 / Scientific statement / narrative review
This American Heart Association scientific statement reviews evidence linking sleep duration and sleep disorders to cardiometabolic health. It notes a decline in average sleep duration among Americans due to curtailing sleep for work, social, or leisure activities. Sleep duration, particularly short sleep, and sleep disorders have emerged as related to adverse cardiometabolic risks, including obesity, hypertension, type 2 diabetes mellitus, and cardiovascular disease. The authors call for health organizations to incorporate evidence-based sleep recommendations into guidelines for optimal health.
Shows an association, not proof of cause and effect.
St-Onge MP, Grandner MA, Brown D, et al. Circulation, 2016. PMID 27647451
2016 / Narrative review
This narrative review examines appetite and reward-induced eating behavior, noting that cravings triggered by food cues activate mesocorticolimbic dopamine pathways and affect weight outcomes. Approved weight-management medications, including naltrexone-bupropion, lorcaserin, liraglutide, and phentermine, show promise or preliminary efficacy in targeting craving-related eating behavior. Additionally, food components such as thylakoid membranes have been shown to influence food cravings.
Rebello CJ, Greenway FL Adv Ther, 2016. PMID 27718159
2016 / Narrative review
This review analyzes the paradoxical relationships and possible mechanisms between fruit intake and anti-obesity effects, addressing why fruits with simple sugars often aid rather than hinder weight reduction. The authors note that health organizations suggest consuming fruit for weight reduction due to its anti-obesity effects and micronutrient content. The review concludes that different types of fruit exert different effects on human body weight.
Shows an association, not proof of cause and effect.
Sharma SP, Chung HJ, Kim HJ, et al. Nutrients, 2016. PMID 27754404
2016 / Position statement
The Academy of Nutrition and Dietetics states that appropriately planned vegetarian, including vegan, diets are healthful, nutritionally adequate, and appropriate for all stages of the life cycle and athletes. Vegetarians and vegans have a reduced risk of conditions such as ischemic heart disease, type 2 diabetes, hypertension, certain cancers, and obesity. Diets low in saturated fat and high in vegetables, fruits, whole grains, legumes, soy, nuts, and seeds yield lower total and LDL cholesterol and improved glucose control. The position statement notes that vegans require reliable sources of vitamin B-12 from fortified foods or supplements.
Melina V, Craig W, Levin S J Acad Nutr Diet, 2016. PMID 27886704
2016 / Narrative review / perspective
The authors discuss that the number of obese people worldwide exceeds those who are underweight, arguing that an 'overfat' pandemic exists involving excess fat mass relative to lean mass that may not be captured by body mass index. Concurrently, the 'underfat' state remains a dangerous circumstance linked to chronic illness and starvation. The article contends that adopting 'overfat' and 'underfat' into common usage may raise awareness and aid prevention and remediation efforts.
Maffetone PB, Rivera-Dominguez I, Laursen PB Front Public Health, 2016. PMID 28097119
2016 / Narrative review
This review examines how calorie restriction impacts the pathophysiology of type 2 diabetes. Negative calorie balance decreases liver fat within days, restoring normal hepatic glucose production control. Over 8 weeks, it allows intra-pancreatic fat levels and first-phase insulin secretion to normalize, supporting the Twin Cycle Hypothesis. The author notes type 2 diabetes can be understood as an excess fat state in the liver and pancreas, remaining reversible for at least 10 years in most individuals.
Taylor R Expert Rev Endocrinol Metab, 2016. PMID 30058916